| The PRISMA 2020 statement: an updated guideline for reporting systematic reviews | BMJ, The | 2021 | 4.5K |
| PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews | BMJ, The | 2021 | 666 |
| The PRISMA 2020 statement: an updated guideline for reporting systematic reviews | Systematic Reviews | 2021 | 513 |
| The PRISMA 2020 statement: An updated guideline for reporting systematic reviews | International Journal of Surgery | 2021 | 461 |
| Age-specific mortality and immunity patterns of SARS-CoV-2 | Nature | 2021 | 399 |
| The PRISMA 2020 statement: An updated guideline for reporting systematic reviews | PLoS Medicine | 2021 | 286 |
| Oxford-AstraZeneca COVID-19 vaccine efficacy | Lancet, The | 2021 | 284 |
| Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program | Nature | 2021 | 268 |
| The PRISMA 2020 statement: An updated guideline for reporting systematic reviews | Journal of Clinical Epidemiology | 2021 | 201 |
| Suicide trends in the early months of the COVID-19 pandemic: an interrupted time-series analysis of preliminary data from 21 countries | Lancet Psychiatry,the | 2021 | 167 |
| Global Tuberculosis Report 2020 - Reflections on the Global TB burden, treatment and prevention efforts | International Journal of Infectious Diseases | 2021 | 132 |
| The Lancet Global Health Commission on Global Eye Health: vision beyond 2020 | The Lancet Global Health | 2021 | 131 |
| The impact of COVID-19 pandemic on physical and mental health of Asians: A study of seven middle-income countries in Asia | PLoS ONE | 2021 | 121 |
| Trust in a COVID-19 vaccine in the U.S.: A social-ecological perspective | Social Science and Medicine | 2021 | 114 |
| Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis | PLoS ONE | 2021 | 111 |
| Antigen-Based Testing but Not Real-Time Polymerase Chain Reaction Correlates With Severe Acute Respiratory Syndrome Coronavirus 2 Viral Culture | Clinical Infectious Diseases | 2021 | 108 |
| Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers | Journal of Clinical Microbiology | 2021 | 101 |
| Repeated Coronavirus Disease 2019 Molecular Testing: Correlation of Severe Acute Respiratory Syndrome Coronavirus 2 Culture With Molecular Assays and Cycle Thresholds | Clinical Infectious Diseases | 2021 | 95 |
| Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited | Cancer Discovery | 2021 | 95 |
| Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis | The Lancet Global Health | 2021 | 93 |
| Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland | Lancet Infectious Diseases, The | 2021 | 92 |
| SARS-CoV-2 Variants in Patients with Immunosuppression | New England Journal of Medicine | 2021 | 92 |
| Economic, Mental Health, HIV Prevention and HIV Treatment Impacts of COVID-19 and the COVID-19 Response on a Global Sample of Cisgender Gay Men and Other Men Who Have Sex with Men | AIDS and Behavior | 2021 | 90 |
| SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals | Journal of Clinical Investigation | 2021 | 89 |
| Patient Trajectories Among Persons Hospitalized for COVID-19 : A Cohort Study | Annals of Internal Medicine | 2021 | 82 |
